RxDoctor Payments Data

Alexandra Carrico, PA

Physician Assistant · Indianapolis, INNPI 1023881661

Payments from drug & device makers

$1,745in general payments, 2019–2025

Across 93 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$293
  • Lilly USA, LLC$283
  • AstraZeneca$233
  • Pfizer$141
  • Bayer$114
  • Exact Sciences$111
  • plus $571 from 17 others

What the payments were for

  • Food & beverage$1,745100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,745 in reported general payments places this provider in the 80th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$19,321
Medicare patients
97
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$12,957
FarxigaDapagliflozin Propanediol11$11,613
Albuterol Sulfate HfaAlbuterol Sulfate22$585
Omeprazole28$475
Buspirone Hcl14$404
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$389
Atorvastatin Calcium39$347
Pregabalin20$346
Gabapentin35$302
Levothyroxine Sodium18$241
Lisinopril22$224
Losartan Potassium27$203
Fluticasone Propionate11$196
Famotidine15$174
Hydroxyzine Hcl16$149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$283$12,95712 claims
AstraZenecaFarxiga$233$11,61311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →